Product Program year 2025 Source: CMS Open Payments

Lumason

Drug Diagnostic Imaging

NDC 0270-7099-16

Open in the dashboard

General payments

$397,738

696 payments

Research payments

$221,399

63 payments

Through program year 2025, $397,738 in general payments and $221,399 in research payments were reported against Lumason (Diagnostic Imaging).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

12 rows
Year Kind Amount Payments
2025 General $160,515 260
2025 Research $85,308 26
2024 General $184,705 139
2024 Research $118,632 13
2023 General $15,624 117
2023 Research $8,605 16
2022 General $25,700 98
2022 Research $2,295 3
2021 General $8,704 40
2021 Research $4,590 4
2020 General $2,491 42
2020 Research $1,969 1

Breakdown

Who paid General payments · program years 2020–2025
  1. Bracco Diagnostics Inc. $397,738 696 payments
Top recipients General payments · program year 2025
  1. Emory University Hospital Teaching hospital · GA $85,000 53% · 1 payment
  2. Rajan Gupta Pain Medicine · Cherry Hill, NJ $27,257 17% · 3 payments
  3. Richard Barr Diagnostic Radiology · Youngstown, OH $24,002 15% · 18 payments
  4. Jordan Strom Cardiovascular Disease · Boston, MA $15,862 10% · 4 payments
  5. Simone Fearon Cardiovascular Disease · Paducah, KY $319 <1% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pain Medicine Physical Medicine & Rehabilitation $27,257 36% · 1 practitioner
  2. Diagnostic Radiology Radiology $24,509 32% · 17 practitioners
  3. Cardiovascular Disease Internal Medicine $19,813 26% · 69 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $463 <1% · 12 practitioners
  5. Internal Medicine $447 <1% · 14 practitioners

The top 5 of 35 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Georgia $86,159 54% · 23 recipients
  2. New Jersey $27,384 17% · 6 recipients
  3. Pennsylvania $24,803 15% · 23 recipients
  4. Massachusetts $16,498 10% · 17 recipients
  5. New York $924 <1% · 23 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Given in the clinic

Part B · billing code
Medicare Part B billing codes matched to Lumason
Billing code Providers Services Paid by Medicare
Injection, sulfur hexafluoride lipid microspheres, per ml Q9950 103 9,249 $132,474

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

696 general · 63 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record